Ken Griffin Atri Cure, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Atri Cure, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 12,600 shares of ATRC stock, worth $470,736. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,600

Previous 9,800 28.57%

Holding current value

$470,736

Previous $298,000 4.03%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$19.86 - $29.09 $3.05 Million - $4.47 Million	-153,610 Reduced 49.98%	153,707 $3.5 Million
Q1 2024 May 15, 2024	BUY	$28.21 - $37.78 $41,412 - $55,461	1,468 Added 0.48%	307,317 $9.35 Million
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $6.94 Million - $9.09 Million	210,251 Added 219.93%	305,849 $10.9 Million
Q3 2023 Nov 14, 2023	SELL	$41.12 - $57.73 $8.87 Million - $12.4 Million	-215,589 Reduced 69.28%	95,598 $4.19 Million
Q2 2023 Aug 14, 2023	SELL	$40.44 - $49.6 $1.16 Million - $1.43 Million	-28,806 Reduced 8.47%	311,187 $15.4 Million
Q1 2023 May 15, 2023	BUY	$35.87 - $47.22 $7.54 Million - $9.92 Million	210,127 Added 161.8%	339,993 $14.1 Million
Q4 2022 Feb 14, 2023	BUY	$33.48 - $47.45 $2.24 Million - $3.18 Million	66,988 Added 106.54%	129,866 $5.76 Million
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $129,093 - $177,592	3,375 Added 5.67%	62,878 $2.46 Million
Q2 2022 Aug 15, 2022	SELL	$35.1 - $66.01 $5.33 Million - $10 Million	-151,745 Reduced 71.83%	59,503 $2.43 Million
Q1 2022 May 16, 2022	SELL	$57.43 - $71.39 $8.75 Million - $10.9 Million	-152,395 Reduced 41.91%	211,248 $13.9 Million
Q4 2021 Feb 14, 2022	SELL	$63.4 - $87.14 $8.69 Million - $11.9 Million	-137,054 Reduced 27.37%	363,643 $25.3 Million
Q3 2021 Nov 15, 2021	SELL	$69.28 - $84.46 $22.7 Million - $27.7 Million	-328,120 Reduced 39.59%	500,697 $34.8 Million
Q2 2021 Aug 16, 2021	BUY	$64.13 - $80.18 $19.8 Million - $24.7 Million	308,656 Added 59.34%	828,817 $65.8 Million
Q1 2021 May 17, 2021	BUY	$53.79 - $66.98 $13.6 Million - $17 Million	253,698 Added 95.21%	520,161 $34.1 Million
Q4 2020 Feb 16, 2021	SELL	$34.56 - $57.55 $288,264 - $480,024	-8,341 Reduced 3.04%	266,463 $14.8 Million
Q3 2020 Nov 16, 2020	BUY	$38.36 - $46.91 $1.33 Million - $1.63 Million	34,747 Added 14.47%	274,804 $11 Million
Q2 2020 Aug 14, 2020	BUY	$31.78 - $51.19 $4.15 Million - $6.68 Million	130,483 Added 119.08%	240,057 $10.8 Million
Q1 2020 May 15, 2020	BUY	$24.49 - $43.84 $1.82 Million - $3.25 Million	74,234 Added 210.06%	109,574 $3.68 Million
Q4 2019 Feb 14, 2020	SELL	$24.06 - $32.51 $1.85 Million - $2.51 Million	-77,061 Reduced 68.56%	35,340 $1.15 Million
Q3 2019 Nov 14, 2019	SELL	$23.81 - $32.52 $1.35 Million - $1.85 Million	-56,879 Reduced 33.6%	112,401 $2.8 Million
Q2 2019 Aug 14, 2019	SELL	$26.85 - $30.74 $1.24 Million - $1.42 Million	-46,214 Reduced 21.45%	169,280 $5.05 Million
Q1 2019 May 15, 2019	BUY	$26.38 - $33.34 $2.06 Million - $2.6 Million	78,037 Added 56.77%	215,494 $0
Q4 2018 Feb 14, 2019	SELL	$26.66 - $34.85 $353,404 - $461,971	-13,256 Reduced 8.8%	137,457 $4.21 Million
Q3 2018 Nov 13, 2018	SELL	$27.62 - $35.58 $201,764 - $259,911	-7,305 Reduced 4.62%	150,713 $0
Q2 2018 Aug 10, 2018	BUY	$19.65 - $30.28 $143,228 - $220,710	7,289 Added 4.84%	158,018 $0
Q1 2018 May 11, 2018	SELL	$15.05 - $21.03 $3.43 Million - $4.79 Million	-227,910 Reduced 60.19%	150,729 $3.09 Million
Q4 2017 Feb 09, 2018	BUY	$17.69 - $23.44 $779,669 - $1.03 Million	44,074 Added 13.17%	378,639 $6.91 Million
Q3 2017 Nov 09, 2017	BUY	$20.0 - $24.23 $6.69 Million - $8.11 Million	334,565	334,565 $7.48 Million

Others Institutions Holding ATRC

# of Institutions

206

Shares Held

48.4M

Call Options Held

111K

Put Options Held

23.8K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.73B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account